News related to Simulect (Basiliximab) and/or conditions it is approved for
Understanding Donor Recipient Genetics Could Decrease Early Kidney Transplant Complications
Source: Transplants / Organ Donations News From Medical News Today [2008.11.26]
Researchers at the University of Pennsylvania School of Medicine have found an association between the genetics of donor-recipient matches in kidney transplants and complications during the first week after transplantation.
ASN: Donor Characteristics Contribute to Recipient Fracture Risk After Kidney Transplant
Source: MedPage Today Surgery [2008.11.11]
PHILADELPHIA (MedPage Today) -- Fractures in the first five years following kidney transplant can be predicted not only by the recipient's risk factors, but also by donor characteristics, researchers said here.
ASN: Delayed Transfer to Adult Care Favored for Teen Kidney Transplant Recipients
Source: MedPage Today Surgery [2008.11.07]
PHILADELPHIA (MedPage Today) -- Pediatric kidney transplant recipients have an almost 50% greater risk of graft failure if they graduate to adult care before the age of 21, suggested a retrospective cohort reported here.
Current Treatments May Eliminate Need for Long-Term Steroids after Kidney Transplant
Source: MedPage Today Dermatology [2008.10.23]
CINCINNATI (MedPage Today) -- Kidney transplant patients on newer immunosuppressants may be able to safely forego chronic use of corticosteroids without increased risk of late graft failure, according to a randomized trial.
Combo Therapy Makes More Kidney Transplants Possible
Source: MedicineNet rituximab Specialty [2008.07.17]
Title: Combo Therapy Makes More Kidney Transplants Possible
Category: Health News
Created: 7/17/2008 2:00:00 AM
Last Editorial Review: 7/17/2008
Study Compares Strategies For BK Virus Nephropathy
Source: Transplants / Organ Donations News From Medical News Today [2008.11.27]
For kidney transplant recipients with a serious complication called BK virus-associated nephropathy (BKVAN), promptly cutting back on anti-rejection drugs reduces the risk of losing the kidney (graft loss), according to a report in the November Clinical Journal of the American Society of Nephrology (CJASN).
|
